A 68-year-old man with non-valvular atrial fibrillation, hypertension and no prior bleeding presents for stroke prevention advice. He has normal renal function and no contraindications to anticoagulation. According to the 2020 CCS atrial fibrillation guideline and CHADS-65 approach, what is the most appropriate antithrombotic strategy?